{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:13:01Z","timestamp":1793391181060,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1053\/j.semdp.2023.11.002","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T05:26:13Z","timestamp":1700198773000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis"],"prefix":"10.1053","volume":"41","author":[{"given":"Michel","family":"Alchoueiry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Henske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2023.11.002_bib0001","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","journal-title":"World J Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2023.11.002_bib0003","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G","article-title":"The Heidelberg classification of renal cell tumours","volume":"183","author":"Kovacs","year":"1997","journal-title":"J Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0004","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.eururo.2005.11.035","article-title":"2004 WHO classification of the renal tumors of the adults","volume":"49","author":"Lopez-Beltran","year":"2006","journal-title":"Eur Urol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0006","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world health organization classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"key":"10.1053\/j.semdp.2023.11.002_bib0007","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.1038\/ncomms13131","article-title":"Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"issue":"7456","key":"10.1053\/j.semdp.2023.11.002_bib0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Cancer genome atlas research n. comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1053\/j.semdp.2023.11.002_bib0009","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2023.11.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.07.006","article-title":"Chromophobe renal cell carcinoma","author":"Henske","year":"2023","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0012","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","article-title":"Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management","volume":"32","author":"Shuch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1053\/j.semdp.2023.11.002_bib0013","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2015.65.6140","article-title":"Von hippel-lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome","volume":"34","author":"Nielsen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0014","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.ackd.2013.10.001","article-title":"Hereditary kidney cancer syndromes","volume":"21","author":"Haas","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"10.1053\/j.semdp.2023.11.002_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000562","article-title":"Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features","volume":"39","author":"Adeniran","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2023.11.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.hoc.2023.04.013","article-title":"Hereditary renal cell carcinoma syndromes","author":"Carlo","year":"2023","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0017","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.seminoncol.2016.09.001","article-title":"Genetic predisposition to kidney cancer","volume":"43","author":"Schmidt","year":"2016","journal-title":"Semin Oncol"},{"issue":"12","key":"10.1053\/j.semdp.2023.11.002_bib0018","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00345-018-2288-5","article-title":"Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management","volume":"36","author":"Maher","year":"2018","journal-title":"World J Urol"},{"issue":"2","key":"10.1053\/j.semdp.2023.11.002_bib0019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ucl.2023.01.010","article-title":"Diseases of hereditary renal cell cancers","volume":"50","author":"Iliopoulos","year":"2023","journal-title":"Urol Clin North Am"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: a metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0021","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/cas.13503","article-title":"Hereditary kidney cancer syndromes: genetic disorders driven by alterations in metabolism and epigenome regulation","volume":"109","author":"Hasumi","year":"2018","journal-title":"Cancer Sci"},{"issue":"24","key":"10.1053\/j.semdp.2023.11.002_bib0022","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","article-title":"Role of VHL gene mutation in human cancer","volume":"22","author":"Kim","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2023.11.002_bib0023","first-page":"298","article-title":"The VHL tumor suppressor gene: insights into oxygen sensing and cancer","volume":"128","author":"Kaelin","year":"2017","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0024","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1681\/ASN.2013090984","article-title":"Beta-catenin links von hippel-lindau to aurora kinase a and loss of primary cilia in renal cell carcinoma","volume":"26","author":"Dere","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0026","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2018.02.020","article-title":"Timing the landmark events in the evolution of clear cell renal cell cancer: tracerx renal","volume":"173","author":"Mitchell","year":"2018","journal-title":"Cell."},{"issue":"8","key":"10.1053\/j.semdp.2023.11.002_bib0027","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13059-014-0433-z","article-title":"Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution","volume":"15","author":"Fisher","year":"2014","journal-title":"Genome Biol"},{"issue":"12","key":"10.1053\/j.semdp.2023.11.002_bib0028","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/3.12.2169","article-title":"Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma","volume":"3","author":"Foster","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0029","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"issue":"15","key":"10.1053\/j.semdp.2023.11.002_bib0030","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","article-title":"Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors","volume":"14","author":"Nickerson","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1053\/j.semdp.2023.11.002_bib0031","first-page":"2852","article-title":"Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas","volume":"54","author":"Shuin","year":"1994","journal-title":"Cancer Res"},{"issue":"24","key":"10.1053\/j.semdp.2023.11.002_bib0032","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1158\/1078-0432.CCR-09-2131","article-title":"Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma","volume":"15","author":"Young","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1053\/j.semdp.2023.11.002_bib0033","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11912-009-0015-5","article-title":"VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy","volume":"11","author":"Cowey","year":"2009","journal-title":"Curr Oncol Rep"},{"issue":"21","key":"10.1053\/j.semdp.2023.11.002_bib0034","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1073\/pnas.91.21.9700","article-title":"Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma","volume":"91","author":"Herman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#","article-title":"Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis","volume":"22","author":"Clifford","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"issue":"12 Pt 1","key":"10.1053\/j.semdp.2023.11.002_bib0036","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1158\/1078-0432.CCR-04-0175","article-title":"Promoter hypermethylation profile of kidney cancer","volume":"10","author":"Dulaimi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2023.11.002_bib0037","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1186\/s12885-016-2688-0","article-title":"Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance","volume":"16","author":"Razafinjatovo","year":"2016","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2023.11.002_bib0038","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/PPO.0b013e3182a102d1","article-title":"PBRM1 and BAP1 as novel targets for renal cell carcinoma","volume":"19","author":"Brugarolas","year":"2013","journal-title":"Cancer J"},{"issue":"9","key":"10.1053\/j.semdp.2023.11.002_bib0039","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"issue":"7","key":"10.1053\/j.semdp.2023.11.002_bib0040","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pena-Llopis","year":"2012","journal-title":"Nat Genet"},{"issue":"8","key":"10.1053\/j.semdp.2023.11.002_bib0041","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of bap1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1053\/j.semdp.2023.11.002_bib0042","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","article-title":"Genotypic and phenotypic features of bap1 cancer syndrome: a report of 8 new families and review of cases in the literature","volume":"153","author":"Haugh","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1053\/j.semdp.2023.11.002_bib0043","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat Genet"},{"issue":"7","key":"10.1053\/j.semdp.2023.11.002_bib0044","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/humu.22090","article-title":"Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development","volume":"33","author":"Duns","year":"2012","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.1014","article-title":"Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma","volume":"44","author":"Guo","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0046","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.urolonc.2014.10.014","article-title":"Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma","volume":"33","author":"Ho","year":"2015","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0047","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"issue":"12","key":"10.1053\/j.semdp.2023.11.002_bib0048","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1158\/1078-0432.CCR-06-0818","article-title":"Targeting the c-Met signaling pathway in cancer","volume":"12","author":"Peruzzi","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1053\/j.semdp.2023.11.002_bib0049","doi-asserted-by":"crossref","first-page":"205","DOI":"10.21037\/atm.2017.03.64","article-title":"MET in human cancer: germline and somatic mutations","volume":"5","author":"Tovar","year":"2017","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.semdp.2023.11.002_bib0051","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","article-title":"Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype","volume":"155","author":"Lubensky","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2023.11.002_bib0052","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1053\/j.semdp.2023.11.002_bib0053","first-page":"1201","article-title":"Tuberous sclerosis-associated renal cell carcinoma. clinical, pathological, and genetic features","volume":"149","author":"Bjornsson","year":"1996","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2023.11.002_bib0054","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2023.11.002_bib0055","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1158\/1541-7786.MCR-11-0302","article-title":"Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma","volume":"9","author":"Kucejova","year":"2011","journal-title":"Mol Cancer Res"},{"issue":"7","key":"10.1053\/j.semdp.2023.11.002_bib0056","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","article-title":"Eosinophilic renal cell tumors with a tsc and mtor gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study","volume":"44","author":"Tjota","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0057","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of tsc2 or mtor characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.11.002_bib0058","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","article-title":"Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations?","volume":"42","author":"Parilla","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.11.002_bib0059","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic loss of tsc genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0060","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41379-021-00816-8","article-title":"TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study","volume":"35","author":"Munari","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0061","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.11.002_bib0062","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (esc rcc): further morphologic and molecular characterization of esc rcc as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0063","first-page":"321","article-title":"Renal cell carcinoma with leiomyomatous stroma: a review of an emerging entity distinct from clear cell conventional renal cell carcinoma","volume":"7","author":"Yeh","year":"2019","journal-title":"Am J Clin Exp Urol"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0064","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\"Renal cell carcinoma with leiomyomatous stroma\" harbor somatic mutations of tsc1, tsc2, mtor, and\/or eloc (tceb1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2023.11.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92688","article-title":"Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma","volume":"2","author":"Casuscelli","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0066","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2023.11.002_bib0067","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.humpath.2020.12.006","article-title":"TSC\/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+\/CK20-\/vimentin-: a validation study","volume":"115","author":"Tjota","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2023.11.002_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2021.06.002","article-title":"Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex","volume":"116","author":"Lerma","year":"2021","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0069","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41379-021-00923-6","article-title":"Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases","volume":"35","author":"Farcas","year":"2022","journal-title":"Mod Pathol"},{"issue":"13","key":"10.1053\/j.semdp.2023.11.002_bib0070","doi-asserted-by":"crossref","first-page":"E1624","DOI":"10.1073\/pnas.1419502112","article-title":"Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn","volume":"112","author":"Hasumi","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"10.1053\/j.semdp.2023.11.002_bib0071","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1038\/onc.2008.261","article-title":"Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL\/Fnip2) protein","volume":"27","author":"Takagi","year":"2008","journal-title":"Oncogene"},{"issue":"42","key":"10.1053\/j.semdp.2023.11.002_bib0072","doi-asserted-by":"crossref","first-page":"15552","DOI":"10.1073\/pnas.0603781103","article-title":"Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling","volume":"103","author":"Baba","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"22","key":"10.1053\/j.semdp.2023.11.002_bib0073","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/jnci\/djs418","article-title":"Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN","volume":"104","author":"Hasumi","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1053\/j.semdp.2023.11.002_bib0074","doi-asserted-by":"crossref","first-page":"e15793","DOI":"10.1371\/journal.pone.0015793","article-title":"Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization","volume":"5","author":"Hong","year":"2010","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1053\/j.semdp.2023.11.002_bib0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.201307084","article-title":"Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases","volume":"202","author":"Petit","year":"2013","journal-title":"J Cell Biol"},{"issue":"34","key":"10.1053\/j.semdp.2023.11.002_bib0076","doi-asserted-by":"crossref","first-page":"24583","DOI":"10.1074\/jbc.M700857200","article-title":"The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in schizosaccharomyces pombe","volume":"282","author":"van Slegtenhorst","year":"2007","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1053\/j.semdp.2023.11.002_bib0077","doi-asserted-by":"crossref","first-page":"e47842","DOI":"10.1371\/journal.pone.0047842","article-title":"Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion","volume":"7","author":"Medvetz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1053\/j.semdp.2023.11.002_bib0078","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.09.044","article-title":"FLCN: the causative gene for Birt-Hogg-Dube syndrome","volume":"640","author":"Schmidt","year":"2018","journal-title":"Gene"},{"issue":"12","key":"10.1053\/j.semdp.2023.11.002_bib0079","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","article-title":"Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons","volume":"113","author":"Birt","year":"1977","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1053\/j.semdp.2023.11.002_bib0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archderm.135.10.1195","article-title":"Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia","volume":"135","author":"Toro","year":"1999","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0081","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-4362.1996.tb03642.x","article-title":"Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome","volume":"35","author":"Chung","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.semdp.2023.11.002_bib0082","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-014-0163-z","article-title":"Renal cell tumour characteristics in patients with the Birt-Hogg-Dube cancer susceptibility syndrome: a retrospective, multicentre study","volume":"9","author":"Benusiglio","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0083","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/iju.13015","article-title":"Birt-Hogg-Dube syndrome: clinical and molecular aspects of recently identified kidney cancer syndrome","volume":"23","author":"Hasumi","year":"2016","journal-title":"Int J Urol"},{"issue":"12","key":"10.1053\/j.semdp.2023.11.002_bib0084","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/bjc.2011.463","article-title":"Renal cancer and pneumothorax risk in Birt-Hogg-Dube syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families","volume":"105","author":"Houweling","year":"2011","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2023.11.002_bib0085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.11694","article-title":"Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma","volume":"109","author":"Nagy","year":"2004","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2023.11.002_bib0086","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/323744","article-title":"Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2","volume":"69","author":"Schmidt","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1053\/j.semdp.2023.11.002_bib0087","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.bjc.6603492","article-title":"Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma","volume":"96","author":"Gad","year":"2007","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0088","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12894-018-0422-8","article-title":"SDH-deficient renal cell carcinoma - clinical, pathologic and genetic correlates: a case report","volume":"18","author":"Kumar","year":"2018","journal-title":"BMC Urol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0089","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2014.86","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.11.002_bib0090","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","article-title":"Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","journal-title":"J Med Genet"},{"issue":"4","key":"10.1053\/j.semdp.2023.11.002_bib0091","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a002584","article-title":"Germline SDHA mutations in children and adults with cancer","volume":"4","author":"Dubard Gault","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0092","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"10.1053\/j.semdp.2023.11.002_bib0093","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"10","key":"10.1053\/j.semdp.2023.11.002_bib0094","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/jclinpath-2021-207830","article-title":"Gene of the month: FH","volume":"74","author":"Zyla","year":"2021","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13023-020-01653-9","article-title":"Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review","volume":"16","author":"Chayed","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0096","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","article-title":"A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients","volume":"44","author":"Lau","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0097","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0098","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/his.13727","article-title":"New and emerging renal entities: a perspective post-WHO 2016 classification","volume":"74","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"issue":"10","key":"10.1053\/j.semdp.2023.11.002_bib0099","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1158\/1078-0432.CCR-20-4367","article-title":"Comprehensive molecular characterization and response to therapy in fumarate hydratase-deficient renal cell carcinoma","volume":"27","author":"Gleeson","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1053\/j.semdp.2023.11.002_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134538","article-title":"Potential role of VHL, PTEN, and BAP1 mutations in renal tumors","volume":"12","author":"Szegedi","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajpath.2013.10.003","article-title":"Epithelial-specific loss of PTEN results in colorectal juvenile polyp formation and invasive cancer","volume":"184","author":"Marsh Durban","year":"2014","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.11.002_bib0102","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.seminoncol.2007.07.009","article-title":"Cowden syndrome","volume":"34","author":"Gustafson","year":"2007","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1053\/j.semdp.2023.11.002_bib0103","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.juro.2013.06.012","article-title":"Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer","volume":"190","author":"Shuch","year":"2013","journal-title":"J Urol"},{"issue":"9","key":"10.1053\/j.semdp.2023.11.002_bib0104","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00018-011-0878-0","article-title":"Genetic alterations of PTEN in human melanoma","volume":"69","author":"Aguissa-Toure","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"5B","key":"10.1053\/j.semdp.2023.11.002_bib0105","first-page":"3841","article-title":"Somatic mutation and homozygous deletion of PTEN\/MMAC1 gene of 10q23 in renal cell carcinoma","volume":"19","author":"Alimov","year":"1999","journal-title":"Anticancer Res"},{"issue":"1\u20132","key":"10.1053\/j.semdp.2023.11.002_bib0106","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejcb.2013.10.002","article-title":"A germline oncogenic MITF mutation and tumor susceptibility","volume":"93","author":"Paillerets","year":"2014","journal-title":"Eur J Cell Biol"},{"issue":"6","key":"10.1053\/j.semdp.2023.11.002_bib0107","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jmg.37.6.446","article-title":"Tietz syndrome (hypopigmentation\/deafness) caused by mutation of MITF","volume":"37","author":"Smith","year":"2000","journal-title":"J Med Genet"},{"issue":"7592","key":"10.1053\/j.semdp.2023.11.002_bib0108","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature16158","article-title":"Corrigendum: a SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"531","author":"Bertolotto","year":"2016","journal-title":"Nature"},{"issue":"7375","key":"10.1053\/j.semdp.2023.11.002_bib0109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","article-title":"A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma","volume":"480","author":"Yokoyama","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1053\/j.semdp.2023.11.002_bib0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pcmr.12047","article-title":"Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history","volume":"26","author":"Ghiorzo","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"10.1053\/j.semdp.2023.11.002_bib0111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215725","article-title":"Exploring the hereditary background of renal cancer in Denmark","volume":"14","author":"Christensen","year":"2019","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1053\/j.semdp.2023.11.002_bib0112","doi-asserted-by":"crossref","first-page":"17051","DOI":"10.1038\/s41598-020-74237-z","article-title":"Cancer risks associated with the germline MITF(E318K) variant","volume":"10","author":"Guhan","year":"2020","journal-title":"Sci Rep"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:24:07Z","timestamp":1760037847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257023000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0740257023000953"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2023.11.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2023.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}